Nidan Laboratories and Healthcare (NSE:NIDAN) Shares Outstanding (Basic Average): 13.9 Mil (As of Mar. 2025)


NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.60
Valuation Possible Value Trap
View Full Analysis

What is Nidan Laboratories and Healthcare Shares Outstanding (Basic Average)?

Nidan Laboratories and Healthcare NSE:NIDAN 67 Shares Outstanding (Basic Average) is 13.9 Mil as of Mar. 2025. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100 (Possible Value Trap).

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Nidan Laboratories and Healthcare's average basic shares outstanding for the quarter that ended in Mar. 2025 was 13.9 Mil.


Nidan Laboratories and Healthcare  (NSE:NIDAN) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Nidan Laboratories and Healthcare Shares Outstanding (Basic Average) Related Terms


Nidan Laboratories and Healthcare Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare Shares Outstanding (Basic Average) Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial 13.90 11.47 13.90 13.90 13.90

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 13.92 13.93 13.87 13.94 13.86
NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nidan Laboratories and Healthcare Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 13.9 Mil mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Shares Outstanding (Basic Average) of 13.9 Mil as of Mar. 2025. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Nidan Laboratories and Healthcare and its competitors.
Is Nidan Laboratories and Healthcare's Shares Outstanding (Basic Average) too high?
Nidan Laboratories and Healthcare's current Shares Outstanding (Basic Average) is 13.9 Mil. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Shares Outstanding (Basic Average) compare to TMO and DHR?
Nidan Laboratories and Healthcare's Shares Outstanding (Basic Average) of 13.9 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Medical Diagnostics & Research company?
A good Shares Outstanding (Basic Average) depends on the Medical Diagnostics & Research industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current Shares Outstanding (Basic Average) is 13.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Nidan Laboratories and Healthcare (NSE:NIDAN) is currently considered Possible Value Trap. The current Shares Outstanding (Basic Average) is 13.9 Mil. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Shares Outstanding (Basic Average) is 13.9 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.60
Price